Skip to main content
. 2018 Aug 6;10(2):352–357. doi: 10.1111/jdi.12894

Figure 1.

Figure 1

Study design. Deg U100, insulin degludec U100; FGM, flash glucose monitoring; Gla300, insulin glargine 300 U/mL; OHA, oral hypoglycemic agent.